These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 31536342)
1. Development of an ENPP1 Fluorescence Probe for Inhibitor Screening, Cellular Imaging, and Prognostic Assessment of Malignant Breast Cancer. Kawaguchi M; Han X; Hisada T; Nishikawa S; Kano K; Ieda N; Aoki J; Toyama T; Nakagawa H J Med Chem; 2019 Oct; 62(20):9254-9269. PubMed ID: 31536342 [TBL] [Abstract][Full Text] [Related]
2. Structure-Aided Development of Small-Molecule Inhibitors of ENPP1, the Extracellular Phosphodiesterase of the Immunotransmitter cGAMP. Carozza JA; Brown JA; Böhnert V; Fernandez D; AlSaif Y; Mardjuki RE; Smith M; Li L Cell Chem Biol; 2020 Nov; 27(11):1347-1358.e5. PubMed ID: 32726585 [TBL] [Abstract][Full Text] [Related]
3. [1,2,4]Triazolo[1,5-a]pyrimidine derivatives: Structure-activity relationship study leading to highly selective ENPP1 inhibitors. Kawaguchi M; Minami S; Ieda N; Nakagawa H Bioorg Med Chem Lett; 2024 Sep; 110():129820. PubMed ID: 38851358 [TBL] [Abstract][Full Text] [Related]
4. ENPP1, an Old Enzyme with New Functions, and Small Molecule Inhibitors-A STING in the Tale of ENPP1. Onyedibe KI; Wang M; Sintim HO Molecules; 2019 Nov; 24(22):. PubMed ID: 31752288 [TBL] [Abstract][Full Text] [Related]
5. ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer. Wang S; Böhnert V; Joseph AJ; Sudaryo V; Skariah G; Swinderman JT; Yu FB; Subramanyam V; Wolf DM; Lyu X; Gilbert LA; Van't Veer LJ; Goodarzi H; Li L Proc Natl Acad Sci U S A; 2023 Dec; 120(52):e2313693120. PubMed ID: 38117852 [TBL] [Abstract][Full Text] [Related]
6. Tumor Exosomal ENPP1 Hydrolyzes cGAMP to Inhibit cGAS-STING Signaling. An Y; Zhu J; Xie Q; Feng J; Gong Y; Fan Q; Cao J; Huang Z; Shi W; Lin Q; Wu L; Yang C; Ji T Adv Sci (Weinh); 2024 May; 11(20):e2308131. PubMed ID: 38498770 [TBL] [Abstract][Full Text] [Related]
7. Human antibodies targeting ENPP1 as candidate therapeutics for cancers. Chu X; Baek DS; Li W; Shyp T; Mooney B; Hines MG; Morin GB; Sorensen PH; Dimitrov DS Front Immunol; 2023; 14():1070492. PubMed ID: 36761762 [TBL] [Abstract][Full Text] [Related]
8. Discovery of Pyrido[2,3- Sun Y; Chen M; Han Y; Li W; Ma X; Shi Z; Zhou Y; Xu L; Yu L; Wang Y; Yu J; Diao X; Meng L; Xu S J Med Chem; 2024 Mar; 67(5):3986-4006. PubMed ID: 38387074 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation studies of novel small molecule ENPP1 inhibitors for cancer immunotherapy. Gangar M; Goyal S; Raykar D; Khurana P; Martis AM; Goswami A; Ghoshal I; Patel KV; Nagare Y; Raikar S; Mukherjee A; Cyriac R; Paquin JF; Kulkarni A Bioorg Chem; 2022 Feb; 119():105549. PubMed ID: 34929517 [TBL] [Abstract][Full Text] [Related]
10. Development of Novel Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Tumor Immunotherapy. Wang X; Lu X; Yan D; Zhou Y; Tan X Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806118 [TBL] [Abstract][Full Text] [Related]
11. Enpp1: a potential facilitator of breast cancer bone metastasis. Lau WM; Doucet M; Stadel R; Huang D; Weber KL; Kominsky SL PLoS One; 2013; 8(7):e66752. PubMed ID: 23861746 [TBL] [Abstract][Full Text] [Related]
12. Development of a High-Throughput Assay to Identify Inhibitors of ENPP1. Kumar M; Lowery RG SLAS Discov; 2021 Jun; 26(5):740-746. PubMed ID: 33402044 [TBL] [Abstract][Full Text] [Related]
14. The role of ENPP1/PC-1 in osteoinduction by calcium phosphate ceramics. Othman Z; Fernandes H; Groot AJ; Luider TM; Alcinesio A; Pereira DM; Guttenplan APM; Yuan H; Habibovic P Biomaterials; 2019 Jul; 210():12-24. PubMed ID: 31048198 [TBL] [Abstract][Full Text] [Related]
15. Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1. Takahashi RU; Miyazaki H; Takeshita F; Yamamoto Y; Minoura K; Ono M; Kodaira M; Tamura K; Mori M; Ochiya T Nat Commun; 2015 Jun; 6():7318. PubMed ID: 26065921 [TBL] [Abstract][Full Text] [Related]
16. Hydrolysis of 2'3'-cGAMP by ENPP1 and design of nonhydrolyzable analogs. Li L; Yin Q; Kuss P; Maliga Z; Millán JL; Wu H; Mitchison TJ Nat Chem Biol; 2014 Dec; 10(12):1043-8. PubMed ID: 25344812 [TBL] [Abstract][Full Text] [Related]
17. Identification of the extracellular membrane protein ENPP3 as a major cGAMP hydrolase and innate immune checkpoint. Mardjuki R; Wang S; Carozza J; Zirak B; Subramanyam V; Abhiraman G; Lyu X; Goodarzi H; Li L Cell Rep; 2024 May; 43(5):114209. PubMed ID: 38749434 [TBL] [Abstract][Full Text] [Related]
18. Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer. Ruiz-Fernández de Córdoba B; Moreno H; Valencia K; Perurena N; Ruedas P; Walle T; Pezonaga-Torres A; Hinojosa J; Guruceaga E; Pineda-Lucena A; Abengózar-Muela M; Cochonneau D; Zandueta C; Martínez-Canarias S; Teijeira Á; Ajona D; Ortiz-Espinosa S; Morales X; Ortiz de Solórzano C; Santisteban M; Ramos-García LI; Guembe L; Strnad V; Heymann D; Hervás-Stubbs S; Pío R; Rodríguez-Ruiz ME; de Andrea CE; Vicent S; Melero I; Lecanda F; Martínez-Monge R Cancer Discov; 2022 May; 12(5):1356-1377. PubMed ID: 35191482 [TBL] [Abstract][Full Text] [Related]
19. The role of HSP70 on ENPP1 expression and insulin-receptor activation. Marucci A; Miscio G; Padovano L; Boonyasrisawat W; Florez JC; Doria A; Trischitta V; Paola RD J Mol Med (Berl); 2009 Feb; 87(2):139-144. PubMed ID: 19083193 [TBL] [Abstract][Full Text] [Related]
20. AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model. Goswami A; Deb B; Goyal S; Gosavi A; Mali M; Martis AM; Khurana P; Gangar M; Raykar D; Mohanty A; Kulkarni A Molecules; 2022 Oct; 27(19):. PubMed ID: 36235254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]